Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
Diabetic kidney disease develops in approximately 40% of diabetic patients and is a major cause of chronic kidney diseases (CKD) and end stage kidney disease (ESKD) worldwide. Hydrogen sulfide (H<sub>2</sub>S), the third gasotransmitter after nitric oxide (NO) and carbon monoxide (CO), i...
Main Authors: | Hai-Jian Sun, Zhi-Yuan Wu, Lei Cao, Meng-Yuan Zhu, Teng-Teng Liu, Lei Guo, Ye Lin, Xiao-Wei Nie, Jin-Song Bian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/15/2857 |
Similar Items
-
The role of hydrogen sulfide in renal system
by: Xu Cao, et al.
Published: (2016-10-01) -
Regulation of Monocytes/Macrophages by the Renin–Angiotensin System in Diabetic Nephropathy: State of the Art and Results of a Pilot Study
by: Claudine Moratal, et al.
Published: (2021-06-01) -
Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological Evidence
by: Bianca Domingues Massolini, et al.
Published: (2020-03-01) -
Efficacy and Safety of Agents in IgA Nephropathy: An Update Network Meta-Analysis
by: Pingping Yang, et al.
Published: (2018-12-01) -
Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3
by: Hai-Jian Sun, et al.
Published: (2021-01-01)